Purpose: Germ-line testing for panels of cancer genes using next-generation sequencing is
becoming more common in clinical care. We report our experience as a clinical laboratory …

Purpose: The aim of the study was to determine the actual GJB2 and GJB6 mutation
frequencies in North America after several years of generalized testing for autosomal recessive …

Newborn screening (NBS) was established as a public health program in the 1960s and is
crucial for facilitating detection of certain medical conditions in which early intervention can …

Purpose: As genome-scale sequencing is increasingly applied in clinical scenarios, a wide
variety of genomic findings will be discovered as secondary or incidental findings, and there …

Gastric adenocarcinoma is the second leading cause of cancer death worldwide. Epstein–Barr
virus (EBV) is present in the malignant cells of approximately 10% of cases. It is unclear …

Mutations in the colony stimulating factor 1 receptor (CSF1R) have recently been discovered
as causal for hereditary diffuse leukoencephalopathy with axonal spheroids. We identified …

BACKGROUND Diff‐Quik–stained fine‐needle aspiration (FNA) smears and touch preparations
from biopsies represent alternative specimens for molecular testing when cell block or …

Purpose Studies suggest that African American women are less likely to pursue BRCA1/2
genetic testing than white women. However, such studies are often confounded by unequal …

Glutaric acidemia type I (GA-I) is an autosomal recessive disorder of the catabolism of lysine,
hydroxylysine, and tryptophan caused by deficiency of glutaryl-CoA dehydrogenase (GCD). …

Responses to warfarin (Coumadin) anticoagulation therapy are affected by genetic variability
in both the CYP2C9 and VKORC1 genes. Validation of pharmacogenetic testing for …